Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial

In an attempt to produce a more defined, clinical-grade version of a vaccine based on Plasmodium falciparum merozoite surface protein 1 (MSP1), we evaluated the efficacy of two recombinant forms of MSP1 in an Aotus nancymai challenge model system. One recombinant vaccine, bvMSP1(42), based on the 42...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Infect Immun
Egile Nagusiak:	Stowers, Anthony W., Cioce, Vittoria, Shimp, Richard L., Lawson, Mark, Hui, George, Muratova, Olga, Kaslow, David C., Robinson, Robin, Long, Carole A., Miller, Louis H.
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2001
Gaiak:	Fungal and Parasitic Infections
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC98053/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11179324/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.3.1536-1546.2001
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial

Antzeko izenburuak